Literature DB >> 1321608

Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase.

A Reith1, G J Rucklidge.   

Abstract

The immunocharacterization of a metalloproteinase isolated from rat glioma cell conditioned medium is described and confirms that the enzyme is identical to type IV collagenase. Free, active plasminogen activator (PA) and PA-PAI complexes were identified as being secreted by the same cells. Using affinity-purified metalloproteinase we demonstrate that the enzyme can be partially activated by u-PA but not by plasmin in vitro. On the basis of these findings and previous published work we propose a scheme for the proteolytic degradation of normal brain tissue during tumour invasion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321608     DOI: 10.1016/s0006-291x(05)80814-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Permeable endothelium and the interstitial space of brain.

Authors:  M W Brightman; M Kaya
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  The intertwined fates of inflammation and coagulation in glioma.

Authors:  Angela Cho; Kelly J McKelvey; Adrian Lee; Amanda L Hudson
Journal:  Mamm Genome       Date:  2018-07-30       Impact factor: 2.957

3.  Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI-27: in vitro study.

Authors:  M Noha; D Yoshida; K Watanabe; A Teramoto
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

Review 4.  Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Authors:  J S Rao; P A Steck; P Tofilon; D Boyd; F Ali-Osman; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B.

Authors:  K Watanabe; D Yoshida; M Noha; A Teramoto
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

6.  Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide.

Authors:  Daizo Yoshida; Kunihiro Watanabe; Masahiro Noha; Hiroshi Takahashi; Akira Teramoto
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 7.  Comparative aspects of neoplastic invasion of the brain.

Authors:  H E Kaiser
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.

Authors:  Takuya Akai; Kenji Niiya; Nobuo Sakuragawa; Hideaki Iizuka; Shunro Endo
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

10.  Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.

Authors:  R E Sawaya; M Yamamoto; Z L Gokaslan; S W Wang; S Mohanam; G N Fuller; I E McCutcheon; W G Stetler-Stevenson; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.